• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?

作者信息

Grundy J E, Shanley J D, Griffiths P D

机构信息

Department of Virology, Royal Free Hospital School of Medicine, London.

出版信息

Lancet. 1987 Oct 31;2(8566):996-9. doi: 10.1016/s0140-6736(87)92560-8.

DOI:10.1016/s0140-6736(87)92560-8
PMID:2889962
Abstract

The conventional explanation for the high fatality rate due to cytomegalovirus (CMV) pneumonitis among allogeneic transplant recipients is that immunosuppression renders the host unable to control replication of this opportunistic agent. However, evidence from studies in man and the murine model of CMV show that virus replication in the lung is unrelated to the development of pathological effects, and that a host immune response is required for the induction of pneumonitis. Thus the hypothesis is that limited CMV replication in the lungs leads to display of a virus-coded protein, which is recognised by host T-cells, and that the pneumonitis is due to an uncontrolled accumulation and recruitment of such cells in the lungs. The reason why CMV is found in the lungs of patients with the acquired immunodeficiency syndrome (AIDS) without producing pneumonitis is probably because these patients cannot mount the pathogenic T-cell response. According to the hypothesis stated here, if the immune capabilities of AIDS patients can be restored, life-threatening CMV pneumonitis may develop.

摘要

相似文献

1
Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?
Lancet. 1987 Oct 31;2(8566):996-9. doi: 10.1016/s0140-6736(87)92560-8.
2
Pulmonary Cytomegalovirus Replication in Renal Transplant Patients with Late Onset Pneumonitis.肾移植患者迟发性肺炎中肺巨细胞病毒的复制
Ann Transplant. 2016 Apr 21;21:235-40. doi: 10.12659/aot.896938.
3
Is the measurement of virus-specific antibody in the lungs of transplant recipients with cytomegalovirus pneumonitis of diagnostic or prognostic value?在患有巨细胞病毒性肺炎的移植受者的肺部测量病毒特异性抗体具有诊断价值还是预后价值?
J Med Virol. 1988 Oct;26(2):197-206. doi: 10.1002/jmv.1890260211.
4
Interstitial pneumonitis in bone marrow transplant recipients is associated with local production of TH2-type cytokines and lack of T cell-mediated cytotoxicity.骨髓移植受者的间质性肺炎与TH2型细胞因子的局部产生及T细胞介导的细胞毒性缺乏有关。
Transplantation. 1997 Jun 27;63(12):1782-9. doi: 10.1097/00007890-199706270-00013.
5
Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts.免疫功能低下宿主巨细胞病毒肺炎的发病机制。
Semin Respir Infect. 1995 Dec;10(4):199-208.
6
Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger?艾滋病患者肺部的巨细胞病毒。是呼吸道病原体还是过客?
Am Rev Respir Dis. 1990 Jun;141(6):1474-7. doi: 10.1164/ajrccm/141.6.1474.
7
Cytomegalovirus (CMV) pneumonitis in AIDS patients: the result of intensive CMV replication?艾滋病患者的巨细胞病毒(CMV)肺炎:CMV大量复制的结果?
Eur Respir J. 1992 Mar;5(3):362-4.
8
Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.评估巨细胞病毒 (CMV)-特异性 T 细胞免疫重建表明,基线抗病毒免疫、预防或抢先治疗,但不是抗胸腺细胞球蛋白治疗有助于肾移植受者的 CMV 特异性 T 细胞重建。
J Infect Dis. 2010 Aug 15;202(4):585-94. doi: 10.1086/654931.
9
The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection.巨细胞病毒在器官中建立潜伏状态与初次感染期间的局部病毒产生无关。
J Gen Virol. 1994 Sep;75 ( Pt 9):2329-36. doi: 10.1099/0022-1317-75-9-2329.
10
Cytomegalovirus induces interstitial lung disease in allogeneic bone marrow transplant recipient rats independent of acute graft-versus-host response.巨细胞病毒在同种异体骨髓移植受体大鼠中诱发间质性肺病,与急性移植物抗宿主反应无关。
Lab Invest. 1996 Feb;74(2):343-52.

引用本文的文献

1
Pathogenesis of human cytomegalovirus in the immunocompromised host.免疫功能低下宿主中人巨细胞病毒的发病机制。
Nat Rev Microbiol. 2021 Dec;19(12):759-773. doi: 10.1038/s41579-021-00582-z. Epub 2021 Jun 24.
2
Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts.免疫功能正常和免疫功能低下宿主中的巨细胞病毒性肝炎
J Clin Transl Hepatol. 2021 Feb 28;9(1):106-115. doi: 10.14218/JCTH.2020.00088. Epub 2021 Jan 4.
3
Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation.对巨细胞病毒再激活的机械通气患者进行抢先使用更昔洛韦治疗。
Ann Intensive Care. 2021 Feb 11;11(1):33. doi: 10.1186/s13613-020-00793-2.
4
Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function.早期研究:通过靶向主要即刻早期基因表达或蛋白功能抑制人巨细胞病毒。
Viruses. 2020 Jan 16;12(1):110. doi: 10.3390/v12010110.
5
Cytomegalovirus (CMV) Pneumonitis: Cell Tropism, Inflammation, and Immunity.巨细胞病毒(CMV)性肺炎:细胞嗜性、炎症和免疫。
Int J Mol Sci. 2019 Aug 8;20(16):3865. doi: 10.3390/ijms20163865.
6
Impact of cytomegalovirus reactivation on clinical outcomes in immunocompetent critically ill patients: protocol for a systematic review and meta-analysis.巨细胞病毒再激活对免疫功能正常的重症患者临床结局的影响:一项系统评价和荟萃分析方案
Syst Rev. 2016 Jul 28;5(1):127. doi: 10.1186/s13643-016-0303-8.
7
Cytomegalovirus reactivation in ICU patients.重症监护病房患者的巨细胞病毒再激活
Intensive Care Med. 2016 Jan;42(1):28-37. doi: 10.1007/s00134-015-4066-9. Epub 2015 Sep 30.
8
Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation.通过病毒在特发性间质性肺炎(非急性加重型)中的核细胞病变效应进行病毒的免疫组织化学检测。
Braz J Med Biol Res. 2013 Nov;46(11):985-992. doi: 10.1590/1414-431X20132885. Epub 2013 Nov 18.
9
Cytomegalovirus pneumonia in hematopoietic stem cell recipients.造血干细胞受体中的巨细胞病毒肺炎
J Intensive Care Med. 2014 Jul-Aug;29(4):200-12. doi: 10.1177/0885066613476454. Epub 2013 Feb 6.
10
Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.开发一种用于测量抗巨细胞病毒抗体中和能力的高通量检测方法。
Clin Vaccine Immunol. 2013 Apr;20(4):540-50. doi: 10.1128/CVI.00644-12. Epub 2013 Feb 6.